Drug profile · INN
cephalexin hydrochloride
KEFTAB
cephalexin hydrochloride (KEFTAB) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — cephalexin hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cephalexin hydrochloride (KEFTAB) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cephalexin hydrochloride?
cephalexin hydrochloride (KEFTAB) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cephalexin hydrochloride?
KEFTAB is a marketed brand name for cephalexin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cephalexin hydrochloride?
cephalexin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.